Evidence map›Paper›PMID 39773847›Full record

ReviewCurrent opinion in HIV and AIDS2025

Role of follicular homing natural killer cells in HIV infection.

Sivasankaran Munusamy Ponnan, Sakthivel Govindaraj, Vijayakumar Velu

Abstract readReview
In one paragraph

Review in Current opinion in HIV and AIDS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sivasankaran Munusamy PonnanSeattle Children's Research Institute, Seattle, Washington.
Sakthivel GovindarajDepartment of Pathology and Laboratory Medicine, Emory Vaccine Center, Emory National Primate Research Center (ENPRC).
Vijayakumar VeluDepartment of Pathology and Laboratory Medicine, Emory Vaccine Center, Emory National Primate Research Center (ENPRC).

Funding

YNPRC NHP CLINICAL MEDICINE RESIDENCY PROGRAM - SUPPLEMENTP51RR000165 · NCRR · EMORY UNIVERSITY · PI RENGARAJAN, JYOTHI · 1985 to 2011
$114.0M
Virology and Molecular Biomarkers CoreP30AI050409 · NIAID · EMORY UNIVERSITY · PI Ann M Chahroudi, Colleen F Kelley · 2002 to 2026
$74.0M
Preclinical Studies and T cell ResponsesU19AI109633 · NIAID · EMORY UNIVERSITY · PI VELU, VIJAYAKUMAR · 2014 to 2018
$10.2M
Combined cytokine therapy for sustained HIV remissionR01AI148377 · NIAID · EMORY UNIVERSITY · PI AMARA, RAMA RAO, VELU, VIJAYAKUMAR · 2020 to 2024
$4.6M
Blocking granzyme-mediated immune suppression to enhance HIV vaccine efficacyR01AI176519 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · PI Vijayakumar Velu, Stephen N. Waggoner · 2023 to 2026
$2.8M
IL-15 Therapy Combined with TGF-Beta Blockade for Sustained HIV RemissionR01AI187162 · NIAID · EMORY UNIVERSITY · PI ANTHONY T PODANY, Vijayakumar Velu · 2025 to 2026
$1.7M
IL-15 Therapy Combined with TGF-Beta Blockade for Sustained HIV RemissionR56AI187162 · NIAID · EMORY UNIVERSITY · PI PODANY, ANTHONY T, VELU, VIJAYAKUMAR · 2024 to 2024
$927k
NCRR NIH HHS P51 RR000165NIAID NIH HHS P30 AI050409NIAID NIH HHS R01 AI148377NIAID NIH HHS R01 AI176519NIAID NIH HHS R01 AI187162NIAID NIH HHS R56 AI187162NIAID NIH HHS U19 AI109633
6 · The paper itself

Abstract

purpose of reviewNatural killer (NK) cells are integral components of the innate immune system, serving a vital function in eliminating virally infected cells. This review highlights the significance of CXCR5+ NK cells in the context of chronic HIV/SIV infection and viral control. RECENT

findingsControlled HIV/SHIV infection results in a substantial increase in the population of CXCR5+ NK cells within the B-cell follicles of secondary lymphoid organs (SLOs). These CXCR5+ NK cells display enhanced functional characteristics, including elevated expression of activation markers and increased cytokine production, which are essential for effective viral control. These follicular NK cells are shown to be enriched in IL-15 signaling, and CXCR5 NK cells are negatively associated with viral burden during chronic HIV and SHIV infection. SUMMARY: The distinct phenotypic and functional attributes of CXCR5+ NK cells, particularly in the lymphoid tissues of individuals living with HIV, emphasize their critical contribution to the anti-HIV-1 immune response. A comprehensive understanding of the mechanisms and roles of CXCR5+ NK cells may present novel therapeutic strategies aimed at enhancing NK-mediated viral control.

Indexed as

HIV-1HIV InfectionsKiller Cells, NaturalSimian Acquired Immunodeficiency SyndromeHumansReceptors, CXCR5Simian Immunodeficiency VirusCXCR5 protein, humanReceptors, CXCR5

Identifiers

PMID39773847
PMCPMC11802284

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.